Veristat Acquisitions

Veristat has acquired 10 companies and its latest acquisition was Instat Clinical Research on Oct 2023

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Instat Clinical Research

Oct 2023

Source »
undisclosed
Instat is a New Jersey-based CRO that offers services such as clinical data management and medical writing for pharmaceutical, medical device and clinical research companies.
Scinopsis SARL

Jun 2023

Source »
undisclosed
Scinopsis is a France-based medical writing consultancy that provides services such as clinical trial documentation and communication for industries including pharma and biotech.
SFL Regulatory Affairs & Scientific Communication GmbH

Mar 2022

Source »
undisclosed
SFL is a Switzerland-based consulting firm that provides services such as quality assurance and medical writing for pharma, biotech and med-tech companies.
Drug Development and Regulation

Nov 2021

Source »
undisclosed
-
Syne Qua Non Limited

Feb 2021

Source »
undisclosed
SQN Clinical is a biometric contract research organization that provides medical writing and quality management services for pharmaceutical sector.

Frequently Asked Questions about Veristat

  1. What companies did Veristat acquire?

    Companies acquired by Veristat include Instat, Scinopsis and SFL
  2. How many acquisitions does Veristat have?

    Veristat has acquired 10 companies including Instat, Scinopsis and SFL.
  1. How many acquisitions did Veristat make in 2023?

    In 2023 Veristat acquired 2 companies including Instat and Scinopsis.